Ledger.Open graph →
SEC Form D · filed April 24, 2025

Apnimed, Inc

Offering
$16.5M
Sold
$16.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Isaac C. Cheng · Cambridge, MADirectorKevin C. Lind · Cambridge, MADirectorFrancois C. Beaubien · Cambridge, MADirectorLawrence G. Miller · Cambridge, MAExec · DirectorJoseph C. Avellone · Cambridge, MADirectorBarry G. Wohl · Cambridge, MAExecGary C. Sender · Cambridge, MADirectorDennis G. Molnar · Cambridge, MAExecPaul C. Fonteyne · Cambridge, MADirectorChris C. Dimitropoulos · Cambridge, MADirectorLawrence G. Miller · Cambridge, MAExec · DirectorPaul C. Fonteyne · Cambridge, MADirectorGary C. Sender · Cambridge, MADirectorJoseph C. Avellone · Cambridge, MADirectorKevin C. Lind · Cambridge, MADirectorDennis G. Molnar · Cambridge, MAExecChris C. Dimitropoulos · Cambridge, MADirectorIsaac C. Cheng · Cambridge, MADirectorFrancois C. Beaubien · Cambridge, MADirectorBarry G. Wohl · Cambridge, MAExecBrian W. Hurley · New York, NYDirectorCraig W. Ruckman · New York, NYExecTony Adams · Lenexa, KSDirectorAlan Townsend · Lenexa, KSDirectorDavid C. Owen · Lenexa, KSExecBrian Linin · Lenexa, KSDirectorRobert W. Fordi · Annapolis, MDExec · DirectorKenneth S. Code · Annapolis, MDDirectorZaiqing Zhu · New York, NYDirectorMichael L. Jones · DALLAS, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗